Primary hyperparathyroidism predicts hypertension: Results from the National Inpatient Sample

Area of Science:

• Endocrinology
• Cardiology
• Public Health

Background:

• Primary hyperparathyroidism (pHPT), often caused by parathyroid adenomas, elevates calcium levels, potentially leading to kidney stones and osteoporosis.
• Previous studies on pHPT and cardiovascular risks have yielded inconsistent results due to small sample sizes and varied disease severity.

Purpose of the Study:

• To investigate the association between primary hyperparathyroidism and cardiovascular risk factors and events using a national registry.
• To determine if pHPT independently predicts cardiovascular outcomes.

Main Methods:

• Utilized the Nationwide Inpatient Sample database (2009-2010) to identify adult patients diagnosed with pHPT (ICD code 252.01).
• Collected data on demographics, cardiovascular risk factors, and event rates.
• Compared pHPT patient data with general population statistics.

Main Results:

• pHPT was identified in 0.1% of hospital admissions (n=37,922).
• The pHPT population showed a higher prevalence of hypertension, diabetes mellitus, hyperlipidemia, obesity, and chronic kidney disease.
• While heart failure and coronary artery disease rates were elevated in the pHPT group, pHPT did not independently predict these conditions after multivariate analysis.
• Primary hyperparathyroidism independently predicted an increased risk of hypertension (OR 1.3; p<0.001).

Conclusions:

• Primary hyperparathyroidism is an independent predictor of hypertension risk in a large patient cohort.
• Despite univariate associations, pHPT did not independently predict heart failure or coronary artery disease.
• Further research is warranted to elucidate the mechanisms linking hypertension and pHPT.